Latest database descriptions

The objective is to establish a major epidemiological representative cohort of the general population and large workforce, in order to contribute to the development of epidemiological research and to provide information regarding public health.

- This is an infrastructure for epidemiological research based on the active workforce, quality and diversity of data and surveillance procedures. Objectives focus on the epidemiology of chronic illness, ageing, behaviour and the environment, as well as determining occupational and social health factors. It may also allow projects to be initiated for various topics, given to the wide accessibility for researchers.

- This is a public health tool that supports the State and CNAMTS public health objectives and assesses the achievement of these objectives through a comprehensive monitoring tool and the collection of diverse information, due to the varied and supplementary methods that call on various data sources.

- This is an epidemiological monitoring tool through a partnership established with the French Institute for Public Health Surveillance (InVS) (particularly on the topic of occupational risk from the Department of Occupational Health (DST)-InVS).

The generalist sample of beneficiaries (EGB) is a 1/97 sample of data from the SNIIR-AM.

The EGB enables a sufficiently large population to be brought together (over 600,000 beneficiaries of the general MSA and RSI plans, identified anonymously, and monitored over 20 years) in order to answer the majority of questions concerning population healthcare behaviour. As such, it is possible to study the amount borne by the patients, the average level of healthcare consumption according to various criteria (age, sex, care for long duration disease (LDD), affiliation with Supplementary Universal Health Insurance (CMUC), follow-up of populations with LDD, such as diabetes (13,000 people in the EGB in 2007), severe chronic respiratory insufficiencies (2,500 people) and Alzheimer's disease (2,000 people).

The EGB random selection method, based on the individual NIRs, largely facilitates longitudinal studies. As the individual’s NIR remains the same throughout their entire life, an EGB beneficiary may be identified in the same way from birth until death.
When this sample is opened to all of the social security schemes, the included individuals will only leave due to death or departure abroad. Therefore, treatment plans for various cohorts of individuals can be monitored with ease.
This sample will make it possible to reconstitute the entire treatment plan for patients over a long period of time, as healthcare consumption data from the SNIIRAM involving general practice and private hospitalisation, are supplemented with reimbursement data for hospitalisations in public institutions, formerly based on global allocation, as well as medical-based hospital information from the PMSI. This reconstitution will be facilitated by the development of the SNIIRAM, which also includes the EGB.

Objectives of the registry in terms of public health (surveillance, assessment):
The tumour registry is the only facility that can assess all of the actions taken over the last 20 years within the département in the field of prevention and screening (breast cancer, prostate cancer, colon-rectum cancer).
The registry monitors incidence and survival for all cancers over time according to all prognostic factors, and provides information on all interval cancers occurring after a negative screening examination.
- Objectives of the registry in terms of research:
The registry is conducting a number of studies (alone or together with other French or European registry networks) to address the need for epidemiological knowledge:
- Descriptive epidemiology: all data concerning cancer in the Hérault département is published and distributed at regular intervals to the whole medical community every two years i.e., incidence and mortality data.
- Analytical epidemiology: relative survival, prevalence, cohort and case-control studies, interval cancers.
- Prognostic factor studies: medico-economic studies, studies on therapies and healthcare channels.
Data from the registry is used by the FRANCIM network in France and by the EUROCARE group at European level to estimate national and regional cancer incidence and prevalence in France, as well as survival analysis.

To determine the epidemiology, clinical profile and therapeutic strategies across 18 procedures (oncology and haematology).